(Q39081778)

8 September 2017

title

Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma: an asian experience (English)

1 reference

8 September 2017

1 reference

Elaine Hsuen Lim

1

1 reference

8 September 2017

Robert Seng Cheong Lim

series ordinal

2

1 reference

8 September 2017

Tuck Seng Wu

series ordinal

3

1 reference

8 September 2017

Hwai Loong Kong

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Annals of Pharmacotherapy

8 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

volume

37

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

1909-1912

1 reference

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

8 September 2017

cites work

1 reference

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel

21 January 2018

1 reference

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer

21 January 2018

1 reference

Racial differences in the response to drugs--pointers to genetic differences

21 January 2018

1 reference

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

21 January 2018

1 reference

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D153

1 reference

8 September 2017

1 reference